5495 results for "*oma"

in 32.31 milliseconds.

• scRNA-seq data from HNSCC samples before and after BA treatment

  Tumor biopsies from 6 head and neck small cell carcinoma (HNSCC) berfore and 3-weeks after bintrafusp-alfa treatment were analyzed using single-cell RNA sequencing (droplet-based 3' 10x genomics). Library were sequenced using the Chromium plateform. Generated fastq files were processed using cellranger to generat the count matrices.

  Dataset EGAD50000003043

• Low-coverage whole-genome sequencing

  Low-coverage whole-genome sequencing from CSF samples collected across timepoints from medulloblastoma patients

  Dataset EGAD50000003058

• Gut microbiota biomarkers associated with Multiple Myeloma: The REMNANT Study

  This dataset contains longitudinal shotgun metagenomic sequencing of stool samples collected across two time points from patients with newly diagnosed multiple myeloma (153 patients , 306 samples total). The suffix "scr" denotes the screening time point, when patients were enrolled in the study and samples were collected before initiation of treatment. Following inclusion, patients received standard multiple myeloma treatment according to Norwegian clinical guidelines. The treatment consisted of four cycles of induction therapy with bortezomib, lenalidomide, and dexamethasone (VRd), followed by autologous stem cell transplantation (ASCT) for eligible patients, and subsequently four cycles of consolidation therapy with VRd. The second stool sample was collected after completion of consolidation therapy. Therefore, samples with the suffix "post_con" represent the post-consolidation time point. This is the time point which MRD was measured. Samples were sequenced on the Illumina NovaSeq X platform. Raw data consists of paired FASTQ files per sample.

  Dataset EGAD50000003072

• Norwegian Sarcoma Consortium Tumor-Normal pairs Whole Exome Sequencing dataset 2026

  The dataset consist of Whole Exome Sequencing results from 287 sarcoma patients in the NoSarC cohort, from which matched sarcoma tumor samples and normal blood samples where pairwise analysed together using the Dragen v.3.7 analysis framework. The dataset contains fastq files as used for input to the analysis and the Dragen 3.7 vcfs outputs for germline mutations, somatic mutations and copy number variants (and their corresponding index files). The phenotype information provided includes: age, sex, times of birth, surgery, death, last followup or last known alive, local recurrence assessment, metastatic-free survival assessment and reccurence-free survival assessment. All times provided in a month-year format. 8 disease and topography fields such as disease status at inclusion, time of WES tumor sampling and final histological diagnosis, as well as tumor lesion sampled and localization of the sarcoma in final diagnosis, are inluced, as well as 5 outcome-related variables incl overall survival and cause of death. Finally 5 treatment-related variables are included. Due to high sequencing depth in several samples, the provided fastq files is the result of a screening process and downsampling if nessearcy, done before the Dragen analysis. The procedure is documented in the included README_fastq_downsampling.txt

  Dataset EGAD50000003102

• Whole-blood RNA-seq in AtezoBev-treated HCC

  This dataset contains RNA-sequencing BAM files generated from paired whole-blood RNA samples collected from patients with advanced hepatocellular carcinoma treated with first-line atezolizumab–bevacizumab immunotherapy. Samples were collected at baseline before the first infusion (T0) and immediately prior to the second infusion (T1). The dataset includes paired longitudinal samples from 24 patients, comprising 13 responders and 11 progressors. RNA sequencing was performed by Novogene using a GlobinClear-based non-directional mRNA library preparation strategy. These data support transcriptomic analyses of circulating immune activation, treatment response and resistance mechanisms under atezolizumab–bevacizumab therapy.

  Dataset EGAD00001016415

• WGS for PDX NB tumours for EGAS00001008494

  WGS from PDX of Neuroblastoma tumours from 4 patients

  Dataset EGAD00001016419

• Paediatric MN1::ZNF341-associated cancer scRNA-seq

  A lethal round-cell malignancy with an MN1::ZNF341 fusion has recently been reported. Here, using single-cell RNA sequencing data derived from monozygotic twins, we find the tumour to be transcriptionally distinct from neuroblastoma. Instead, it exhibits steroidogenic differentiation. These data, in combination with the clinical, radiological, histopathological and additional molecular findings, corroborate suggestions that this tumour is a distinct and aggressive childhood cancer.

  Dataset EGAD00001016421

• Subset of dataset EGAD00001010108

  This is a subset of data from EGAD00001010108 containing WES/RNA/WGS TFCP2-rearranged rhabdomyosarcoma samples.

  Dataset EGAD00001016432

• Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma of gallbladder patient

  Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma of gallbladder patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016435

• Genome and transcriptome sequence data from a metastatic primary cns melanoma patient

  Genome and transcriptome sequence data from a metastatic primary cns melanoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016436

• Genome and transcriptome sequence data from a hepatoid carcinoma of the pancreas patient

  Genome and transcriptome sequence data from a hepatoid carcinoma of the pancreas patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016444

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016447

• Genome and transcriptome sequence data from a metastatic undifferentiated pleomorphic sarcoma of uterus patient

  Genome and transcriptome sequence data from a metastatic undifferentiated pleomorphic sarcoma of uterus patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016449

• Genome and transcriptome sequence data from a poorly differentiated thyroid carcinoma with rhabdoid features patient

  Genome and transcriptome sequence data from a poorly differentiated thyroid carcinoma with rhabdoid features patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016450

• Genome and transcriptome sequence data from a metastatic pulmonary adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pulmonary adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016452

• Genome and transcriptome sequence data from a clear cell sarcoma patient

  Genome and transcriptome sequence data from a clear cell sarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016455

• Genome and transcriptome sequence data from a left humeral parosteal osteosarcoma with foci of de-differentiation patient

  Genome and transcriptome sequence data from a left humeral parosteal osteosarcoma with foci of de-differentiation patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016458

• Genome and transcriptome sequence data from a acral melanoma patient

  Genome and transcriptome sequence data from a acral melanoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016459

• Genome and transcriptome sequence data from a radiation induced osteosarcoma patient

  Genome and transcriptome sequence data from a radiation induced osteosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016461

• Genome and transcriptome sequence data from a uterine leiomyosarcoma patient

  Genome and transcriptome sequence data from a uterine leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016462

• Genome and transcriptome sequence data from a rectal adenocarcinoma patient

  Genome and transcriptome sequence data from a rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002973

• Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002974

• Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma of unknown primary patient

  Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma of unknown primary patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002975

• Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient

  Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002976

• Genome and transcriptome sequence data from a metastatic fibrolamellar hepatocelluar carcinoma patient

  Genome and transcriptome sequence data from a metastatic fibrolamellar hepatocelluar carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002980

• Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002981

• Genome and transcriptome sequence data from a metastatic rectosigmoid adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic rectosigmoid adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002982

• Genome and transcriptome sequence data from a metastatic carcinoma of the lung patient

  Genome and transcriptome sequence data from a metastatic carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002983

• Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002984

• Genome and transcriptome sequence data from a adenocarcinoma of the lung patient

  Genome and transcriptome sequence data from a adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002985

• Genome and transcriptome sequence data from a metastatic endocervical adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic endocervical adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002987

• Genome and transcriptome sequence data from a cholangiocarcinoma patient

  Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002991

• Genome and transcriptome sequence data from a metastatic carcinoma of primary unknown patient

  Genome and transcriptome sequence data from a metastatic carcinoma of primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002993

• Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of anus patient

  Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of anus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002994

• Genome and transcriptome sequence data from a carcinosarcoma of the uterus patient

  Genome and transcriptome sequence data from a carcinosarcoma of the uterus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002995

• Genome and transcriptome sequence data from a leiomyosarcoma patient

  Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001002996

• Genome and transcriptome sequence data from a serous carcinoma of fallopian tube patient

  Genome and transcriptome sequence data from a serous carcinoma of fallopian tube patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003001

• Genome and transcriptome sequence data from a glioblastoma multiforme patient

  Genome and transcriptome sequence data from a glioblastoma multiforme patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003004

• Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient

  Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003005

• Genome and transcriptome sequence data from a metastatic adenocarcinoma presumably of ovarian origin patient

  Genome and transcriptome sequence data from a metastatic adenocarcinoma presumably of ovarian origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003008

• Genome and transcriptome sequence data from a metastatic uterine leiomyosarcoma patient

  Genome and transcriptome sequence data from a metastatic uterine leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003010

• Genome and transcriptome sequence data from a squamous cell carcinoma of the lung patient

  Genome and transcriptome sequence data from a squamous cell carcinoma of the lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003011

• Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectum patient

  Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001003012

• Genome and transcriptome sequence data from a metastatic low rectal adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic low rectal adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016629

• Genome and transcriptome sequence data from a locally recurrent oropharyngeal squamous cell carcinoma patient

  Genome and transcriptome sequence data from a locally recurrent oropharyngeal squamous cell carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016630

• Genome and transcriptome sequence data from a clear cell sarcoma, primary of the right foot patient

  Genome and transcriptome sequence data from a clear cell sarcoma, primary of the right foot patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016631

• Genome and transcriptome sequence data from a recurrent myofibroblastic sarcoma, to lung patient

  Genome and transcriptome sequence data from a recurrent myofibroblastic sarcoma, to lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016632

• Genome and transcriptome sequence data from a neuroendocrine carcinoma of lung patient

  Genome and transcriptome sequence data from a neuroendocrine carcinoma of lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016636

• Genome and transcriptome sequence data from a metastatic myoepithelial parotid carcinoma to the lungs patient

  Genome and transcriptome sequence data from a metastatic myoepithelial parotid carcinoma to the lungs patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016637

• Genome and transcriptome sequence data from a high grade myoepithelial carcinoma patient

  Genome and transcriptome sequence data from a high grade myoepithelial carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016639